Incannex Healthcare (IXHL) EBIT Margin: 2020-2025

Historic EBIT Margin for Incannex Healthcare (IXHL) over the last 6 years, with Jun 2025 value amounting to -27,661.63%.

  • Incannex Healthcare's EBIT Margin fell 12742865.00% to -135,880.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 59,339.02%, marking a year-over-year change of. This contributed to the annual value of -27,661.63% for FY2025, which is 22268004.00% up from last year.
  • Per Incannex Healthcare's latest filing, its EBIT Margin stood at -27,661.63% for FY2025, which was up 88.95% from -250,341.67% recorded in FY2024.
  • Over the past 5 years, Incannex Healthcare's EBIT Margin peaked at -651.38% during FY2021, and registered a low of -250,341.67% during FY2024.
  • For the 3-year period, Incannex Healthcare's EBIT Margin averaged around -93,870.40%, with its median value being -27,661.63% (2025).
  • In the last 5 years, Incannex Healthcare's EBIT Margin plummeted by 24,673,376bps in 2024 and then soared by 22,268,004bps in 2025.
  • Over the past 5 years, Incannex Healthcare's EBIT Margin (Yearly) stood at -651.38% in 2021, then crashed by 122,962bps to -1,881.00% in 2022, then slumped by 172,690bps to -3,607.90% in 2023, then crashed by 24,673,376bps to -250,341.67% in 2024, then soared by 22,268,004bps to -27,661.63% in 2025.